Mission
LAACClamp Inc’s mission is to enhance the lives of cardiac surgery patients by creating innovative, cost-efficient, and user-friendly surgical devices.
Mission
LAACClamp Inc’s mission is to enhance the lives of cardiac surgery patients by creating innovative, cost-efficient, and user-friendly surgical devices.
Conforms to the base of the
left atrial appendage
Problem
Closure of the left atrial appendage (LAA) reduces the risk for stroke in patients with AF and in high-risk patients undergoing open heart surgery. The base of the LAA is a curved structure. All current surgical LAA closure devices are linear – making it challenging to place precisely at the base of the LAA, leaving a risk for a residual stump and an ongoing risk of stroke. Additionally, all current surgical LAA closure devices are accompanied by complex delivery systems.
Our Solution
LAACClamp Inc is developing innovative surgical devices designed to completely close the heart’s left atrial appendage (LAA), a major source of stroke-causing blood clots. Currently in pre-clinical development, LAACClamp™ is uniquely curved to conform to the natural anatomy of the LAA, enabling surgeons to place the device precisely at its base. It’s easy to implant using off-the-shelf surgical instruments, eliminating bulky delivery systems and lowering costs. LAACClamp facilitates LAA closure in a more cost-efficient manner for cardiac surgeons worldwide.
Problem
Closure of the left atrial appendage (LAA) reduces the risk for stroke in patients with AF and in high-risk patients undergoing open heart surgery. The base of the LAA is a curved structure. All current surgical LAA closure devices are linear – making it challenging to place precisely at the base of the LAA, leaving a risk for a residual stump and an ongoing risk of stroke. Additionally, all current surgical LAA closure devices are accompanied by complex delivery systems.
Simple, complete exclusion of the left atrial appendage
Our Solution
LAACClamp Inc is developing innovative surgical devices designed to completely close the heart’s left atrial appendage (LAA), a major source of stroke-causing blood clots. Currently in preclinical development, LAACClamp™ is uniquely curved to conform to the natural anatomy of the LAA, enabling surgeons to place the device precisely at its base. It’s easy to implant using off-the-shelf surgical instruments, eliminating bulky delivery systems and lowering costs. LAACClamp makes LAA closure easier, more effective, and more cost-efficient for cardiac surgeons worldwide.
Investors
Intellectual Property
USPTO 18/962,737 Issued October 7, 2025
USPTO 18/962,711 Issued 3/31/2026
Multiple Patents Pending
Team
Email: info@laacclamp.com
1275 Kinnear Rd,
Columbus, OH, 43212
LAACClamp™ Inc was established as a Delaware C-Corp in November 2023 to commercialize cardiac surgery innovations created by founder Nahush A Mokadam, MD, Cardiac Surgeon, Inventor. The Company has secured an exclusive worldwide license to this platform from The Ohio State University.
Nahush A Mokadam, MD
Founder, Chairman and CSO
Gary L Smith, MBA,
CEO
Advisors and Partners
Team
Email: info@laacclamp.com
1275 Kinnear Rd,
Columbus, OH, 43212
LAACClamp™ Inc was established as a Delaware C-Corp in November 2023 to commercialize cardiac surgery innovations created by founder Nahush A Mokadam, MD, Cardiac Surgeon, Inventor. The Company has secured an exclusive worldwide license to this platform from The Ohio State University.
Nahush A Mokadam, MD
Founder, Chairman and CSO
Gary L Smith, MBA,
CEO
LAACClamp™ has not yet
been cleared by the FDA.
